CY2407B1 - Acellular pertussis vaccine with diphthriae- and tetanus-toxoids. - Google Patents

Acellular pertussis vaccine with diphthriae- and tetanus-toxoids.

Info

Publication number: CY2407B1
Authority: CY; Cyprus
Prior art keywords: diphthriae; toxoids; tetanus; pertussis vaccine; acellular pertussis
Prior art date: 1996-11-07

Application number

CY0400014A

Other languages

English (en)

Inventor

Patrick Florent

Jean Stephenne

Christian Vandecasserie

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-07

Filing date

2004-02-26

Publication date

2004-09-10

2004-02-26 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

2004-09-10 Publication of CY2407B1 publication Critical patent/CY2407B1/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

CY0400014A 1996-11-07 2004-02-26 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids. CY2407B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9623233.5A GB9623233D0 (en)	1996-11-07	1996-11-07	Vaccine composition

Publications (1)

Publication Number	Publication Date
CY2407B1 true CY2407B1 (en)	2004-09-10

Family

ID=10802615

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CY0400014A CY2407B1 (en)	1996-11-07	2004-02-26	Acellular pertussis vaccine with diphthriae- and tetanus-toxoids.
CY0600031A CY2568B1 (en)	1996-11-07	2006-11-09	Acellular pertussis vaccine with diphtheriae- and tetanus- toxoids

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
CY0600031A CY2568B1 (en)	1996-11-07	2006-11-09	Acellular pertussis vaccine with diphtheriae- and tetanus- toxoids

Country Status (30)

Country	Link
EP (2)	EP0941117B1 (fr)
JP (1)	JP3980652B2 (fr)
KR (1)	KR100518044B1 (fr)
CN (1)	CN1130226C (fr)
AR (1)	AR011509A1 (fr)
AT (2)	ATE222773T1 (fr)
AU (1)	AU710475B2 (fr)
BR (2)	BR9712917A (fr)
CA (1)	CA2271008C (fr)
CO (1)	CO4910171A1 (fr)
CY (2)	CY2407B1 (fr)
CZ (1)	CZ295954B6 (fr)
DE (3)	DE69715031T2 (fr)
DK (2)	DK1240905T5 (fr)
ES (2)	ES2182131T3 (fr)
GB (1)	GB9623233D0 (fr)
HK (1)	HK1050473B (fr)
HU (1)	HU224126B1 (fr)
IL (1)	IL129530A (fr)
LU (1)	LU91183I2 (fr)
NO (2)	NO320186B1 (fr)
NZ (1)	NZ335384A (fr)
PL (1)	PL188460B1 (fr)
PT (2)	PT1240905E (fr)
SA (1)	SA98181128B1 (fr)
SI (2)	SI1240905T1 (fr)
TR (1)	TR199900979T2 (fr)
TW (1)	TW471971B (fr)
WO (1)	WO1998019702A1 (fr)
ZA (1)	ZA979984B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1004314A1 (fr) *	1998-11-26	2000-05-31	Pasteur Merieux MSD	Vaccin T.d. Polio rappel pour une population vaccinée ou sensibilisée
KR100374813B1 (ko) *	2000-04-07	2003-03-03	녹십자백신 주식회사	디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법
GB0108364D0 (en) *	2001-04-03	2001-05-23	Glaxosmithkline Biolog Sa	Vaccine composition
KR100401423B1 (ko) *	2001-01-10	2003-10-17	주식회사 엘지생명과학	혼합 백신의 제조 방법
JP5007425B2 (ja) *	2006-01-30	2012-08-22	財団法人ヒューマンサイエンス振興財団	百日咳ワクチンの安全性評価方法
GB0616306D0 (en) *	2006-08-16	2006-09-27	Novartis Ag	Vaccines
GB0822633D0 (en) *	2008-12-11	2009-01-21	Novartis Ag	Formulation
AU2010290896B2 (en)	2009-09-02	2014-07-03	Glaxosmithkline Biologicals S.A.	Immunogenic compositions including TLR activity modulators
MX343914B (es)	2010-09-01	2016-11-18	Glaxosmithkline Biologicals Sa	Adsorcion de inmunopotenciadores en sales metalicas insolubles.
US20140112950A1 (en)	2011-03-02	2014-04-24	Manmohan Singh	Combination vaccines with lower doses of antigen and/or adjuvant
CN102363041A (zh) *	2011-11-17	2012-02-29	成都欧林生物科技股份有限公司	不含防腐剂疫苗的制作工艺
JP6345603B2 (ja)	2012-03-08	2018-06-20	ノバルティスアーゲー	追加免疫ワクチンのアジュバント化された処方物
CN102793915B (zh) *	2012-07-25	2013-10-23	天津康希诺生物技术有限公司	一种无细胞百日咳疫苗的生产方法
US20140037680A1 (en)	2012-08-06	2014-02-06	Glaxosmithkline Biologicals, S.A.	Novel method
SG11201500573RA (en)	2012-08-06	2015-02-27	Glaxosmithkline Biolog Sa	Method for eliciting in infants an immune response against rsv and b. pertussis
CN103100081A (zh) *	2012-12-26	2013-05-15	天津康希诺生物技术有限公司	一种多价联合疫苗
CN105007936B (zh)	2013-03-08	2018-10-02	扬森疫苗与预防公司	无细胞百日咳疫苗
AU2014304545A1 (en)	2013-08-05	2016-02-25	Glaxosmithkline Biologicals S.A.	Combination immunogenic compositions
CN114748616A (zh) *	2022-05-23	2022-07-15	中国医学科学院医学生物学研究所	一种成人青少年用无细胞百白破联合疫苗及其制备方法
CN117417419B (zh) *	2023-01-10	2024-04-19	康希诺生物股份公司	一种百日咳毒素脱毒方法及无细胞百白破联合疫苗
CN119524117B (zh) *	2025-01-23	2025-09-23	康希诺生物股份公司	免疫原性组合物、百白破联合疫苗及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI861417A0 (fi)	1985-04-15	1986-04-01	Endotronics Inc	Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4895800A (en)	1985-11-26	1990-01-23	Phillips Petroleum Company	Yeast production of hepatitis B surface antigen
EP0278940A3 (fr)	1987-01-30	1988-12-07	Smithkline Biologicals S.A.	Antigènes de surface de virus de l'hépatite B et antigènes hybridés les contenant
EP0304578B1 (fr)	1987-06-22	2001-10-24	Medeva Holdings Bv	Peptide contenant l'antigène de surface de l'hépatite B
EP0299108B1 (fr)	1987-07-17	1994-05-18	Rhein Biotech Gesellschaft für biotechnologische Prozesse und Produkte mbH	Molécules d'ADN codant pour les régions de contrôle de FMDH et gène structurel pour une protéine ayant l'activité du FMDH et leur utilisation
EP0414374B1 (fr)	1989-07-25	1997-10-08	Smithkline Biologicals S.A.	Antigènes ainsi que les méthodes pour leur préparation
GB9007024D0 (en)	1990-03-29	1990-05-30	Imperial College	Novel vaccine
DE69319728T2 (de)	1992-05-23	1999-02-04	Smithkline Beecham Biologicals S.A., Rixensart	Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten

1996
- 1996-11-07 GB GBGB9623233.5A patent/GB9623233D0/en active Pending
1997
- 1997-11-04 HU HU9904287A patent/HU224126B1/hu active IP Right Grant
- 1997-11-04 SI SI9730706T patent/SI1240905T1/xx unknown
- 1997-11-04 WO PCT/EP1997/006180 patent/WO1998019702A1/fr not_active Ceased
- 1997-11-04 BR BR9712917-8A patent/BR9712917A/pt not_active IP Right Cessation
- 1997-11-04 AU AU53196/98A patent/AU710475B2/en not_active Expired
- 1997-11-04 EP EP97950137A patent/EP0941117B1/fr not_active Expired - Lifetime
- 1997-11-04 CA CA002271008A patent/CA2271008C/fr not_active Expired - Lifetime
- 1997-11-04 DE DE69715031T patent/DE69715031T2/de not_active Expired - Lifetime
- 1997-11-04 KR KR10-1999-7004016A patent/KR100518044B1/ko not_active Expired - Lifetime
- 1997-11-04 DK DK02075821T patent/DK1240905T5/da active
- 1997-11-04 DE DE69733285T patent/DE69733285T3/de not_active Expired - Lifetime
- 1997-11-04 EP EP02075821A patent/EP1240905B3/fr not_active Expired - Lifetime
- 1997-11-04 JP JP52107098A patent/JP3980652B2/ja not_active Expired - Lifetime
- 1997-11-04 SI SI9730394T patent/SI0941117T1/xx unknown
- 1997-11-04 CN CN97199491A patent/CN1130226C/zh not_active Expired - Lifetime
- 1997-11-04 ES ES97950137T patent/ES2182131T3/es not_active Expired - Lifetime
- 1997-11-04 ES ES02075821T patent/ES2240647T7/es active Active
- 1997-11-04 TR TR1999/00979T patent/TR199900979T2/xx unknown
- 1997-11-04 NZ NZ335384A patent/NZ335384A/xx not_active IP Right Cessation
- 1997-11-04 BR BRPI9712917A patent/BRPI9712917B8/pt unknown
- 1997-11-04 DK DK97950137T patent/DK0941117T3/da active
- 1997-11-04 PT PT02075821T patent/PT1240905E/pt unknown
- 1997-11-04 PT PT97950137T patent/PT941117E/pt unknown
- 1997-11-04 CZ CZ19991640A patent/CZ295954B6/cs not_active IP Right Cessation
- 1997-11-04 AT AT97950137T patent/ATE222773T1/de active
- 1997-11-04 AT AT02075821T patent/ATE295178T1/de active
- 1997-11-04 IL IL12953097A patent/IL129530A/xx not_active IP Right Cessation
- 1997-11-06 AR ARP970105177A patent/AR011509A1/es active IP Right Grant
- 1997-11-06 ZA ZA979984A patent/ZA979984B/xx unknown
- 1997-11-07 CO CO97065487A patent/CO4910171A1/es unknown
- 1997-12-24 TW TW086119712A patent/TW471971B/zh not_active IP Right Cessation
1998
- 1998-04-25 SA SA98181128A patent/SA98181128B1/ar unknown
1999
- 1999-05-04 NO NO19992156A patent/NO320186B1/no not_active IP Right Cessation
- 1999-05-05 PL PL97333127A patent/PL188460B1/pl unknown
2000
- 2000-03-10 HK HK03101055.7A patent/HK1050473B/en not_active IP Right Cessation
2004
- 2004-02-26 CY CY0400014A patent/CY2407B1/xx unknown
2005
- 2005-06-16 DE DE200512000046 patent/DE122005000046I1/de active Pending
- 2005-07-20 LU LU91183C patent/LU91183I2/fr unknown
2006
- 2006-04-25 NO NO2006005C patent/NO2006005I2/no unknown
- 2006-11-09 CY CY0600031A patent/CY2568B1/xx unknown

Also Published As

Publication number	Publication date
EP1240905B3 (fr)	2009-08-26
SA98181128B1 (ar)	2006-03-25
ES2240647T7 (es)	2010-03-31
IL129530A (en)	2005-11-20
BR9712917A (pt)	1999-12-07
ZA979984B (en)	1998-07-23
NO992156D0 (no)	1999-05-04
CN1236321A (zh)	1999-11-24
NO2006005I2 (no)	2010-04-12
TW471971B (en)	2002-01-11
NO2006005I1 (no)	2006-05-08
NO320186B1 (no)	2005-11-07
EP0941117A1 (fr)	1999-09-15
ATE222773T1 (de)	2002-09-15
DE122005000046I1 (de)	2005-12-29
CZ295954B6 (cs)	2005-12-14
HK1050473A1 (en)	2003-06-27
DE69715031T2 (de)	2003-05-08
HUP9904287A1 (hu)	2000-04-28
GB9623233D0 (en)	1997-01-08
IL129530A0 (en)	2000-02-29
BRPI9712917B1 (pt)	2019-12-03
HK1022638A1 (en)	2000-08-18
KR100518044B1 (ko)	2005-09-30
WO1998019702A1 (fr)	1998-05-14
PT941117E (pt)	2002-12-31
PL333127A1 (en)	1999-11-22
CA2271008A1 (fr)	1998-05-14
DE69733285T3 (de)	2010-03-25
AU5319698A (en)	1998-05-29
AU710475B2 (en)	1999-09-23
DE69733285D1 (de)	2005-06-16
PT1240905E (pt)	2005-09-30
PL188460B1 (pl)	2005-02-28
ATE295178T1 (de)	2005-05-15
CO4910171A1 (es)	2000-04-24
HUP9904287A3 (en)	2001-05-28
CZ164099A3 (cs)	1999-10-13
ES2240647T3 (es)	2005-10-16
CN1130226C (zh)	2003-12-10
NZ335384A (en)	2000-10-27
EP1240905A1 (fr)	2002-09-18
LU91183I2 (fr)	2005-09-20
DK1240905T3 (da)	2005-07-18
DK1240905T5 (da)	2010-01-11
JP3980652B2 (ja)	2007-09-26
SI0941117T1 (en)	2002-12-31
KR20000053092A (ko)	2000-08-25
CA2271008C (fr)	2008-07-22
JP2001503422A (ja)	2001-03-13
EP1240905B1 (fr)	2005-05-11
DE69733285T2 (de)	2006-01-12
HK1050473B (en)	2006-03-03
SI1240905T1 (en)	2005-10-31
HU224126B1 (hu)	2005-05-30
TR199900979T2 (xx)	1999-07-21
BRPI9712917B8 (pt)	2021-05-25
NO992156L (no)	1999-05-04
DK0941117T3 (da)	2002-11-18
ES2182131T3 (es)	2003-03-01
AR011509A1 (es)	2000-08-30
EP0941117B1 (fr)	2002-08-28
CY2568B1 (en)	2008-07-02
DE69715031D1 (de)	2002-10-02

Publication	Publication Date	Title
GB9620795D0 (en)	1996-11-20	Vaccines
ZA9811849B (en)	2000-06-23	Vaccine.
ZA984969B (en)	1999-12-09	Vaccine.
ZA988789B (en)	2000-03-29	Vaccine.
ZA9710209B (en)	1998-06-03	Disinfecting microemulsions.
HUP9904287A3 (en)	2001-05-28	Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids
EP0958373A4 (fr)	2001-11-28	Vaccins
ZA976815B (en)	1998-05-11	Vaccine composition.
ZA975034B (en)	1998-01-14	Airship.
GB9410922D0 (en)	1994-07-20	Vaccines
GB9626864D0 (en)	1997-02-12	Vaccine
GB9625968D0 (en)	1997-01-29	Vaccine
ZA939564B (en)	1994-08-15	Vaccines.
EP0681480A4 (fr)	1997-06-25	Vaccins a base de recognine.
ZA973824B (en)	1998-08-20	Vaccines
ZA967198B (en)	1998-02-23	Vaccines.
AU715243C (en)	2001-01-18	Acellular antibordetella vaccine
ZA952806B (en)	1995-12-19	Vaccines
GB9605229D0 (en)	1996-05-15	Vaccines
GB9602617D0 (en)	1996-04-10	Vaccines
GB9604595D0 (en)	1996-05-01	Vaccines
GB9606032D0 (en)	1996-05-22	Vaccines
GB9626882D0 (en)	1997-02-12	Vaccines
GB9614182D0 (en)	1996-09-04	Vaccines
ZA987303B (en)	2000-02-14	Vaccine.